SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-108760
Filing Date
2018-04-05
Accepted
2018-04-05 16:25:56
Documents
9
Period of Report
2018-05-18
Effectiveness Date
2018-04-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A d473986ddef14a.htm DEF 14A 340144
2 GRAPHIC g47398603.jpg GRAPHIC 6422
3 GRAPHIC g473986g56e86.jpg GRAPHIC 36045
4 GRAPHIC g473986grpahic1.jpg GRAPHIC 38150
5 GRAPHIC g473986grpahic2.jpg GRAPHIC 47327
6 GRAPHIC g473986grpahic3.jpg GRAPHIC 8683
7 GRAPHIC g473986grpahic4.jpg GRAPHIC 19700
8 GRAPHIC g473986grpahic5.jpg GRAPHIC 13604
9 GRAPHIC g473986grpahic6.jpg GRAPHIC 47008
  Complete submission text file 0001193125-18-108760.txt   641061
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35945 | Film No.: 18740857
SIC: 2834 Pharmaceutical Preparations